D-0169-2021 Class II Terminated

Recalled by Hikma Pharmaceuticals USA Inc. — Cherry Hill, NJ

Recall Details

Product Type
Drugs
Report Date
December 23, 2020
Initiation Date
December 7, 2020
Termination Date
July 18, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,324,072 vials

Product Description

Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/ml, 2mL Single Dose Vial, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, Vial NDC 0641-0497-17

Reason for Recall

Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2ml vial.

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Lot#: 048315 EXP 4/2021; 068320 EXP 6/2021; 128302 EXP 12/2021; 099349 EXP 9/2022.